Bilionea Jeff Bezos aunda jopo la Wataalam kuangalia namna ya kuzuia kifo

Hakuna cha kuzuia wala kuchelewesha ukiona ndugu yako kachomoka baada ya kuugua miaka 30 ujue ndio ilikuwa siku yake ya kuondoka. Kwa wakongwe wenzangu watakumbuka miaka ya 80 mwishoni ilitoka khabari toka KCMC pana mgonjwa alikaa hospital miaka 27 nadhani lilikuwa gazeti la motomoto au mfanyakazi lilitoa khabari hiyo.
 
Hakuna cha kuzuia wala kuchelewesha ukiona ndugu yako kachomoka baada ya kuugua miaka 30 ujue ndio ilikuwa siku yake ya kuondoka. Kwa wakongwe wenzangu watakumbuka miaka ya 80 mwishoni ilitoka khabari toka KCMC pana mgonjwa alikaa hospital miaka 27 nadhani lilikuwa gazeti la motomoto au mfanyakazi lilitoa khabari hiyo.
 


Amazon ex-CEO Jeff Bezos has been looking to space for humanity's future. But the world's richest man is also trying to extend humanity's lifespan here on Earth, according to a report in MIT's Technology Review.

Bezos, who is worth an estimated $200 billion, is one of several investors in Altos Labs, a Silicon Valley startup working on technology to rejuvenate cells and potentially prolong life, the Technology Review reported. The startup also counts Yuri Milner, an Israeli-Russian tech billionaire and founder of the $3 million Breakthrough Prizes, as a backer.

Altos Labs is working on what's called reprogramming technology, a method of reverting adult, specialized cells into stem cells, which have the potential to turn into any kind of cell, according to the Massachusetts Institute of Technology's Technology Review.

Scientists say reprogramming holds great potential to treat vision loss, spinal cord injuries, brain injuries and other age-related bodily degeneration. In a 2018 study, the Salk Institute biochemist Juan Carlos Izpisua Belmonte declared it "the elixir of life" and said that "aging is not an irreversible process." The following year, Izpisua Belmonte was part of a team working in China that created monkey-human hybrids called chimeras, drawing criticism from medical ethicists.

Now, Izpisua Belmonte is set to join Altos Labs, according to the Technology Review. Other preeminent scientists are also joining the startup's staff, including Steve Horvath, a University of California geneticist who developed a way to detect the aging of cells from their molecular markers. Shinya Yamanaka, who received a Nobel prize for his work on reprogramming in 2012 will head Altos Labs' advisory board., Technology Review reported.

Stopping disease and prolonging life seems to be a key interest for Bezos. In his 2020 letter to Amazon shareholders, the 57-year-old Amazon founder quotes extensively from British evolutionary biologist, Richard Dawkins, writing to his investors: "Staving off death is a thing that you have to work at. … if living things didn't work actively to prevent it, they would eventually merge into their surroundings, and cease to exist as autonomous beings. That is what happens when they die."

Concluded Bezos in his shareholder letter: "Never, never, never let the universe smooth you into your surroundings."

Bezos Expeditions, the billionaire's investment firm, did not reply to a request for comment from CBS MoneyWatch.

The multi-billionaire holds stakes in several other startups conducting cellular research, according to Bezos Expeditions, including Nautilus Biotechnology, Sana Biotechnology, Denali Therapeutics and Juno Therapeutics (now part of Bristol Myers Squibb).

Along with fellow tech billionaire Peter Thiel, Bezos has also invested in Unity Biotechnology, a startup developing technology to delay aging at the cellular level.

The project of staving off death is a popular one in Silicon Valley. In 2013, Google launched Calico, a research and development lab to treat aging. One year later, the Palo Alto Longevity Prize offered $1 million for researchers who could turn old organisms young or extend a living creature's lifespan by 50%. Today, researchers from 50 countries can take a crack at some $30 million in prizes available through the National Academy of Medicine's "healthy longevity" challenge.

Nir Barzilai, director of the Institute for Aging Research at Albert Einstein College of Medicine in New York, expects $4.5 billion to be invested in life-extending science this year, he told the New York Post.

View attachment 2095287
This is nothing more than JEURI YA PESA! No more no less!
 
Tatizo Cell zinakufa na inafika wakati zinaacha ku-regenerate..., wakiweza tu ku-plant information zake kwa mwingine watakuwa wameweza kuzuia kifo (yaani everything is in the Brain)

Tukiweza kuchukua memory yako hata ukahihamishia kwenye a synthesized body basi utakuwa umeepuka kifo (au kama tukiweza kufanya hibernation) yaani ukalala miaka 50 alafu ukashituka huenda ukawa umepunguza aging..., ila tatizo eventually utazeeka....

What is Born must Die.....

Tatizo kifo kipo wakati wote kabla uhai , kifo kimeanza mwanzo kabla uhai huwezi kukiepuka wala kukizuia
 
Hapo ndipo unapoona Mungu hadhihakiwi, Binadamu huwa anapenda sana kushindana na muumba wake. Mpaka leo hawajui inakuwaje sperms zikikutana na yai la kike zinatengeneza mtoto, hapo wameshindwa kufanya utafiti wao
Acha woga wa kijinga. Uliumbwa kwa mfano wake halafu unakuwa na uwoga wa kiboya boya. Wakati wa ugunduzi wa ndege kulikuwa na watu kama wewe, wakasema binadamu angetakiwa kupaa angeumbwa na mabawa. Leo tuna ndege.

Huyu tajiri anajaribu jambo la kipekee, akifa kabla halijatimia basi atakayerithi hataanza moja ataanzia alipoishia, halafu ukisoma hiyo habari si suala la kuishi milele ni suala la kurefusha maisha, mambo ya magonjwa sijui ya figo, corona yasiue watu, By the way, inasemekana waoga hawataiona mbingu.
 
Acha woga wa kijinga. Uliumbwa kwa mfano wake halafu unakuwa na uwoga wa kiboya boya. Wakati wa ugunduzi wa ndege kulikuwa na watu kama wewe, wakasema binadamu angetakiwa kupaa angeumbwa na mabawa. Leo tuna ndege.

Huyu tajiri anajaribu jambo la kipekee, akifa kabla halijatimia basi atakayerithi hataanza moja ataanzia alipoishia, halafu ukisoma hiyo habari si suala la kuishi milele ni suala la kurefusha maisha, mambo ya magonjwa sijui ya figo, corona yasiue watu, By the way, inasemekana waoga hawataiona mbingu.
""inasemekana waoga hawataiona mbingu""
 
Hao wadau wa US wanatamani kuendelea kukaa duniani kula raha. Jeff ni mmoja tu aliyesimama mbele kufuatilia Immortality ila kiuhalisia wengi wanatazamani waweze kuishi kwa kipindi kirefu.

Hapo kuna Hoax za kutosha zitapeperushwa kupitia majarida ya Sayansi na Teknolojia huko Ulaya na Marekani Kaskazini.

Don't be a fool, life is for living not straining
 
Hao wadau wa US wanatamani kuendelea kukaa duniani kula raha. Jeff ni mmoja tu aliyesimama mbele kufuatilia Immortality ila kiuhalisia wengi wanatazamani waweze kuishi kwa kipindi kirefu.

Hapo kuna Hoax za kutosha zitapeperushwa kupitia majarida ya Sayansi na Teknolojia huko Ulaya na Marekani Kaskazini.

Don't be a fool, life is for living not straining

Mfuko Wake umejaa inahitaji wajanja wautoboe Na wao wale ndiyo dunia ilipofika
 
tuongee ukweli jamaa akifanikiwa kuna mtu ambaye atakataa hii huduma kweli
 
Chanzo cha kifo ni dhambi. Chanzo cha kifo ni lile tunda la kati. Yani atakufa na utafiti wake maana hakuna njia kumrudisha binadam kwenye ujana maana dhambi ina mtafuna mpaka umauti... Aka dhambi ya asili...
 
Chanzo cha kifo ni dhambi. Chanzo cha kifo ni lile tunda la kati. Yani atakufa na utafiti wake maana hakuna njia kumrudisha binadam kwenye ujana maana dhambi ina mtafuna mpaka umauti... Aka dhambi ya asili...
Umeandika Chanzo cha kifo ni dhambi , hivi maneno haya uliyapata wapi ???
 


Amazon ex-CEO Jeff Bezos has been looking to space for humanity's future. But the world's richest man is also trying to extend humanity's lifespan here on Earth, according to a report in MIT's Technology Review.

Bezos, who is worth an estimated $200 billion, is one of several investors in Altos Labs, a Silicon Valley startup working on technology to rejuvenate cells and potentially prolong life, the Technology Review reported. The startup also counts Yuri Milner, an Israeli-Russian tech billionaire and founder of the $3 million Breakthrough Prizes, as a backer.

Altos Labs is working on what's called reprogramming technology, a method of reverting adult, specialized cells into stem cells, which have the potential to turn into any kind of cell, according to the Massachusetts Institute of Technology's Technology Review.

Scientists say reprogramming holds great potential to treat vision loss, spinal cord injuries, brain injuries and other age-related bodily degeneration. In a 2018 study, the Salk Institute biochemist Juan Carlos Izpisua Belmonte declared it "the elixir of life" and said that "aging is not an irreversible process." The following year, Izpisua Belmonte was part of a team working in China that created monkey-human hybrids called chimeras, drawing criticism from medical ethicists.

Now, Izpisua Belmonte is set to join Altos Labs, according to the Technology Review. Other preeminent scientists are also joining the startup's staff, including Steve Horvath, a University of California geneticist who developed a way to detect the aging of cells from their molecular markers. Shinya Yamanaka, who received a Nobel prize for his work on reprogramming in 2012 will head Altos Labs' advisory board., Technology Review reported.

Stopping disease and prolonging life seems to be a key interest for Bezos. In his 2020 letter to Amazon shareholders, the 57-year-old Amazon founder quotes extensively from British evolutionary biologist, Richard Dawkins, writing to his investors: "Staving off death is a thing that you have to work at. … if living things didn't work actively to prevent it, they would eventually merge into their surroundings, and cease to exist as autonomous beings. That is what happens when they die."

Concluded Bezos in his shareholder letter: "Never, never, never let the universe smooth you into your surroundings."

Bezos Expeditions, the billionaire's investment firm, did not reply to a request for comment from CBS MoneyWatch.

The multi-billionaire holds stakes in several other startups conducting cellular research, according to Bezos Expeditions, including Nautilus Biotechnology, Sana Biotechnology, Denali Therapeutics and Juno Therapeutics (now part of Bristol Myers Squibb).

Along with fellow tech billionaire Peter Thiel, Bezos has also invested in Unity Biotechnology, a startup developing technology to delay aging at the cellular level.

The project of staving off death is a popular one in Silicon Valley. In 2013, Google launched Calico, a research and development lab to treat aging. One year later, the Palo Alto Longevity Prize offered $1 million for researchers who could turn old organisms young or extend a living creature's lifespan by 50%. Today, researchers from 50 countries can take a crack at some $30 million in prizes available through the National Academy of Medicine's "healthy longevity" challenge.

Nir Barzilai, director of the Institute for Aging Research at Albert Einstein College of Medicine in New York, expects $4.5 billion to be invested in life-extending science this year, he told the New York Post.

View attachment 2095287
Hii imeanza muda mrefu, ila sizani kama watafanikiwa.

 

Similar Discussions

Back
Top Bottom